Tuesday 7 June 2016

FIRST TO FILE RACE for Daliresp tablet

Torrent pharma, Micro lab, Zydus pharma, Stride pharma, Apotex corp., Citron pharma, Hetero, Prinston, Breckenridge and Mylan Pharmaceutical (Total 10 ANDA Filer) are defendants against Takeda (Innovator of Daliresp)- Plaintiff.




Stride pharma has already got tentative approval for its ANDA filing of Roflumilast tablet 500MCG, generic version of Deliresp tablet.

Roflumilast tablets, used for the treatment of inflammatory conditions of the lungs and around $174 million of sale.


FIRST TO FILE RACE for Daliresp

No comments:

Post a Comment